Search

Your search keyword '"Verdier, M. C."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Verdier, M. C." Remove constraint Author: "Verdier, M. C."
37 results on '"Verdier, M. C."'

Search Results

4. Therapeutic drug monitoring of ruxolitinib in graft versus host disease in pediatric allogenic hematopoietic stem cell transplant recipients: A multicenter retrospective study

5. An easy, fast and inexpensive multiplex pharmacogenetics assay to simultaneously analyze 17 clinically relevant genetic polymorphisms in CYP3A4, CYP3A5, CYP1A2, CYP2C9, CYP2C19, CYP2D6, ABCB1 and VKORC1 genes

6. Contribution of voriconazole phenotyping to patient management

8. Deciphering pharmacogenetic-whole blood/intracellular pharmacokinetic-pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients

9. Redefining therapeutic drug monitoring of tacrolimus in liver transplantation: can we target trough concentrations below 7 ng/ml during the first month?

10. Pharmacokinetic-pharmacodynamic profile in patients treated with ceftaroline: A retrospective study

11. A case report of a therapeutic drug monitoring-guided sofosbuvir-velpatasvir crushed treatment

12. Validation of a high-performance liquid chromatography-tandem mass spectrometry method for the quanYtification of beta-lactams in cardiac valves

13. Tacrolimus is a P-glycoprotein but not a multidrug resistance-associated proteins or a concentrative nucleoside transporter 3 substrate

16. Pharmacokinetic and pharmacodynamic profile of beta-lactam antibiotics in patients treated for infective endocarditis a five-year retrospective study

17. Beta-lactams and Proton Pump Inhibitors a new example of renal transporters mediated drug-drug interaction

18. Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies

19. Storage at room temperature does not change cisatracurium onset time: A prospective, randomized, double-blind controlled study (vol 31, pg 783, 2012)

20. Erratum to “Storage at room temperature does not change cisatracurium onset time: A prospective, randomized, double-blind controlled study [Ann. Fr. Anesth. Reanim. 31 (2012) 783–787]

21. Population kinetics of factor VIII in mild hemophilia A patients following desmopressin intravenous administration

23. Vancomycin collection in heparin plasma tube: is there an influence of heparin on vancomycin concentration?

24. Sirolimus severe overdosage following co-treatment with the new tablet formulation of posaconazole (Noxafil (R)): a case report

25. Managing drug-drug interaction between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir and Mycophenolate mofetil

26. Therapeutic drug monitoring of ganciclovir in CMV infections: Should we reassess the therapeutic range?

28. Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies.

33. Moxifloxacin-rifampicin combination for the treatment of non-staphylococcal Gram-positive orthopedic implant-related infections.

34. Colistin-containing cement spacer for treatment of experimental carbapenemase-producing Klebsiella pneumoniae prosthetic joint infection.

35. Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation.

36. [Storage at room temperature does not change cisatracurium onset time: a prospective, randomized, double-blind controlled study].

37. Assessment of interindividual variability of plasma concentrations after administrazion of high doses of intravenous amoxicillin or cloxacillin in critically ill patients.

Catalog

Books, media, physical & digital resources